Literature DB >> 20206138

Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin.

Marco Leonti1, Laura Casu, Stefan Raduner, Filippo Cottiglia, Costantino Floris, Karl-Heinz Altmann, Jürg Gertsch.   

Abstract

The skin irritant polyyne falcarinol (panaxynol, carotatoxin) is found in carrots, parsley, celery, and in the medicinal plant Panax ginseng. In our ongoing search for new cannabinoid (CB) receptor ligands we have isolated falcarinol from the endemic Sardinian plant Seseli praecox. We show that falcarinol exhibits binding affinity to both human CB receptors but selectively alkylates the anandamide binding site in the CB(1) receptor (K(i)=594nM), acting as covalent inverse agonist in CB(1) receptor-transfected CHO cells. Given the inherent instability of purified falcarinol we repeatedly isolated this compound for biological characterization and one new polyyne was characterized. In human HaCaT keratinocytes falcarinol increased the expression of the pro-allergic chemokines IL-8 and CCL2/MCP-1 in a CB(1) receptor-dependent manner. Moreover, falcarinol inhibited the effects of anandamide on TNF-alpha stimulated keratinocytes. In vivo, falcarinol strongly aggravated histamine-induced oedema reactions in skin prick tests. Both effects were also obtained with the CB(1) receptor inverse agonist rimonabant, thus indicating the potential role of the CB(1) receptor in skin immunopharmacology. Our data suggest anti-allergic effects of anandamide and that falcarinol-associated dermatitis is due to antagonism of the CB(1) receptor in keratinocytes, leading to increased chemokine expression and aggravation of histamine action. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206138     DOI: 10.1016/j.bcp.2010.02.015

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  18 in total

1.  The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.

Authors:  A Chicca; J Marazzi; J Gertsch
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors.

Authors:  Shivani Sachdev; Kiran Vemuri; Samuel D Banister; Mitchell Longworth; Michael Kassiou; Marina Santiago; Alexandros Makriyannis; Mark Connor
Journal:  Br J Pharmacol       Date:  2019-12-10       Impact factor: 8.739

Review 3.  Phytocannabinoids beyond the Cannabis plant - do they exist?

Authors:  Jürg Gertsch; Roger G Pertwee; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 4.  Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Authors:  Jürg Gertsch
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

5.  The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors.

Authors:  R Baur; J Gertsch; E Sigel
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

6.  Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors.

Authors:  Mark Bauer; Andrea Chicca; Marco Tamborrini; David Eisen; Raissa Lerner; Beat Lutz; Oliver Poetz; Gerd Pluschke; Jürg Gertsch
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

Review 7.  Transition from inflammation to proliferation: a critical step during wound healing.

Authors:  Ning Xu Landén; Dongqing Li; Mona Ståhle
Journal:  Cell Mol Life Sci       Date:  2016-05-14       Impact factor: 9.261

8.  Trends in ginseng research in 2010.

Authors:  Si-Kwan Kim; Jeong Hill Park
Journal:  J Ginseng Res       Date:  2011-11       Impact factor: 6.060

9.  A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ.

Authors:  Yuval Ramot; Koji Sugawara; Nóra Zákány; Balázs I Tóth; Tamás Bíró; Ralf Paus
Journal:  PeerJ       Date:  2013-02-19       Impact factor: 2.984

Review 10.  Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.

Authors:  John M McPartland; Geoffrey W Guy; Vincenzo Di Marzo
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.